Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.
about
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsProteomics investigations of HDL: challenges and promiseCurrent Awareness on Comparative and Functional GenomicsAPOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema.HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approachNanoparticle size and surface properties determine the protein corona with possible implications for biological impactsHuman body fluid proteome analysis.Localized-statistical quantification of human serum proteome associated with type 2 diabetesIntegrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometryProteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality.Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry.Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.microRNAs and HDL life cycle.A proteome signature for intrauterine growth restriction derived from multifactorial analysis of mass spectrometry-based cord blood serum profiling.Anti-oxidant properties of high-density lipoprotein and atherosclerosisGenomic approaches to coronary artery diseaseBiochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy.Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions.Uremia alters HDL composition and functionAcute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in menTestosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacityPreparation and activity analysis of recombinant human high-density lipoproteinA comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteinsA Comparison of Methods To Enhance Protein Detection of Lipoproteins by Mass SpectrometryIdentification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein InteractionRosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory PropertiesThematic review series: systems biology approaches to metabolic and cardiovascular disorders. Proteomics approaches to the systems biology of cardiovascular diseases.Cardiovascular proteomics: past, present, and future.The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosisTyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular Diels-Alder cyclization.Distinctive proteomic profiles among different regions of human carotid plaques in men and women.HDL and endothelial protection.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisElucidation of lipoprotein particles structure by proteomic analysis.Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complexProteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyondThe HDL proteome: a marker--and perhaps mediator--of coronary artery disease.
P2860
Q24669594-70ACA33A-2D88-4D4F-8152-5B977D2AD934Q26774903-52D99E77-4233-463D-8476-ED688F01934BQ27000995-AA312B7B-8F78-4522-8C63-6574522D70EEQ27486415-C9B7F5A2-DE4B-4244-BC42-4BB555B1E688Q28387051-2CBD2778-59A5-461C-8D16-0348E1EC1517Q28481613-0E3E11FE-9929-4CF5-9CAE-AD64930052F3Q28651929-50190C5A-902D-47A3-B23D-E16A2DB19BBCQ33262623-0FD3AE2C-5D3A-4ACE-B54A-09135C700A53Q33369848-A9934D83-7A6B-49D1-A5F8-18E854AAB450Q33675323-A50C5868-5B6B-4CAE-AC2F-8C3F908A44E4Q33752486-AE3413E6-9BDF-4395-B851-E237CC99ECE0Q33980120-8E5E836C-FA8F-46A2-A06B-43AF38023879Q34053599-F28FC67C-9E7B-45CC-A139-B044839C4B07Q34094985-83070034-0330-45A3-AD2E-E2C9406A13AEQ34155049-4F3D620D-49E0-4084-89A6-0D5C9C5D1DABQ34248289-C13A4647-D304-42B0-A7F2-391CF723DC4DQ34319554-E01146BD-F6A9-4301-8A46-D3AE89047D6BQ34440172-5B0575C2-DBDC-4804-A4D7-11FF6B3BB177Q34530017-1CD1868B-4408-4721-BFB4-C56B3D119BC2Q34578113-A725EDC6-337A-46EE-ADF3-4BE7EC570C24Q35149530-050037FD-F720-4BF3-8C81-5B182862790CQ35210194-23038E62-A7D9-45DC-8C8B-A5E39C6CE39FQ35831025-3F0BD286-5083-490B-8777-FBD08AC49822Q36020300-618744CB-7F19-4799-8305-E9EB4DF5E58BQ36297930-D5FFD12D-E559-47C7-BE4D-25CD3CDB635BQ36459901-80C884F0-353B-4755-95F6-977F51B0CC22Q36467197-623095DD-5B55-45C1-9242-99383CE98D79Q36489313-1E12CF26-DB1B-47DA-80F0-DE23EE5425CAQ36604395-B8F081AA-818D-4D0D-9694-0FC7F21B6562Q36634821-1AB225BA-59C9-49AA-8976-1114F4366374Q36775610-E9ECB857-6F76-46A4-BFFD-095F2D328749Q36790267-EFDC40AA-A03D-4B0F-B3CE-4B5F5F5B6CD6Q36916720-6C3B2462-08D9-4EBD-86B0-793D95A9E9FBQ36919051-C5B0CEFC-08AC-4D0C-BF74-7FC2D7C9992EQ36929420-F5C9E071-5602-40E4-91C4-F1A7C14FEE77Q36955395-F9555AD0-E17D-4B0C-8477-DD199236636CQ37087392-8E55154E-D421-4599-95AE-E6EAD3A053E2Q37123887-B0817BC9-3B4F-49E1-9682-7B56F9AF514FQ37162996-AF0C1807-E30D-4265-B3A8-A6BF3CA4B8B2Q37173205-526DC079-911B-41D5-AD88-37827A4C7D2A
P2860
Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Lipoproteomics II: mapping of ...... horesis and mass spectrometry.
@ast
Lipoproteomics II: mapping of ...... horesis and mass spectrometry.
@en
type
label
Lipoproteomics II: mapping of ...... horesis and mass spectrometry.
@ast
Lipoproteomics II: mapping of ...... horesis and mass spectrometry.
@en
prefLabel
Lipoproteomics II: mapping of ...... horesis and mass spectrometry.
@ast
Lipoproteomics II: mapping of ...... horesis and mass spectrometry.
@en
P2093
P356
P1433
P1476
Lipoproteomics II: mapping of ...... horesis and mass spectrometry.
@en
P2093
Christer Tagesson
Helen Karlsson
Mats Lindahl
Per Leanderson
P304
P356
10.1002/PMIC.200401010
P577
2005-04-01T00:00:00Z